Inflammatory bowel disease (IBD) is a chronic relapsing–remitting systemic disease of the
gastrointestinal tract. It is well established that the gut microbiome has a profound impact on …

Inflammatory bowel disease (IBD) includes Crohn's disease (CD) and ulcerative colitis (UC)
and comprises a chronic gastrointestinal tract disorder characterized by hyperactive and …

This commentary provides background, historical context, and a critical assessment of the
concept that microbial dysbiosis drives the pathogenesis of periodontal diseases. It is long …

Obesity, a risk to health, is a global problem in modern society. The prevalence of obesity
was approximately 13% among world's adult population. Recently, several reports …

BACKGROUND Crohn's disease (CD) represents a significant public health challenge. We
identified a combination of beneficial probiotic strains (Saccharomyces boulardii …

As a severe public health problem, methamphetamine (METH) abuse places a heavy
burden on families and society. A growing amount of evidence has indicated communication …

The Kono-S anastomosis was introduced in 2011 as an alternative anastomosis in Crohn's
disease (CD) surgery. Since then, prevailing evidence of the favorable results of the Kono-S …

Background Gut microbial alteration is implicated in inflammatory bowel disease but is noted
in other diseases. Systematic comparison to define similarities and specificities is hampered …

The direct/indirect responsibility of the gut microbiome in disease induction in and outside
the digestive tract is well studied. These results are usually from the overpopulation of …

Inflammatory bowel disease (IBD) is a multi‐factorial autoimmune disorder that its causative
agents are unknown. The gut microbiota comprises of bacteria, viruses, fungi and protozoa …